Burkhoff, Daniel

COVID-19 and cardiovascular disease

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,738

Invasive left ventricle pressure–volume analysis: overview and practical clinical implications

Bastos, M. B., Burkhoff, D., Maly, J., Daemen, J., den Uil, C. A., Ameloot, K., Lenzen, M., Mahfoud, F., Zijlstra, F., Schreuder, J. J., et al. (2020) · European Heart Journal

Cardiovascular Function and Risk FactorsHemodynamic Monitoring and Therapy

Cited by 237

Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction

Sorimachi, H., Burkhoff, D., Verbrugge, F. H., Omote, K., Obokata, M., Reddy, Y. N. V., Takahashi, N., Sunagawa, K., & Borlaug, B. A. (2021) · European Journal of Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 124

Central and peripheral determinants of exercise capacity in heart failure patients with preserved ejection fraction

Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S. P., van Veldhuisen, D. J., Ponikowski, P., et al. (2019) · JACC Heart Failure

Cardiovascular and exercise physiologyHeart Failure Treatment and Management

Cited by 43